1. Home
  2. SFNC vs NUVB Comparison

SFNC vs NUVB Comparison

Compare SFNC & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simmons First National Corporation

SFNC

Simmons First National Corporation

HOLD

Current Price

$19.28

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$9.47

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFNC
NUVB
Founded
1903
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SFNC
NUVB
Price
$19.28
$9.47
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$22.75
$10.63
AVG Volume (30 Days)
1.1M
6.8M
Earning Date
01-20-2026
11-03-2025
Dividend Yield
4.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$26,748,000.00
Revenue This Year
$27.12
$609.55
Revenue Next Year
$7.58
$197.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1137.19
52 Week Low
$17.00
$1.54
52 Week High
$23.44
$9.53

Technical Indicators

Market Signals
Indicator
SFNC
NUVB
Relative Strength Index (RSI) 56.93 74.81
Support Level $19.01 $8.13
Resistance Level $19.83 $8.95
Average True Range (ATR) 0.41 0.54
MACD 0.04 -0.01
Stochastic Oscillator 52.86 96.87

Price Performance

Historical Comparison
SFNC
NUVB

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: